Skip to main content
SpringerLink
Log in

A Guide to Venous Thromboembolism Risk Factor Assessment

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. National Institutes of Health. Consensus conference on prevention of venous thromboembolism. JAMA 1986;256:744–748.

    Google Scholar 

  2. Cardiovascular Disease Educational and Research Trust. European Consensus Conference on Prevention of Venous Thromboembolism. Int Angiol 1992;2:151–159.

    Google Scholar 

  3. Franzeck UK, Schalch I, Jager KA, et al. Prospective 12-year follow up study of clinical and hemodynamic sequelae after deep vein thrombosis in low-risk patients (Zurich study). Circulation 1996;93:74–94.

    Google Scholar 

  4. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep vein thrombosis. Ann Intern Med 1996;125:1–7.

    Google Scholar 

  5. Miller ML. Chronic venous insufficiency. Curr Opin Cardiol 1995;10:543–548.

    Google Scholar 

  6. Rutherford RB. Pathogenesis and pathophysiology of the post-thrombotic syndrome: Clinical implications. Semin Vasc Surg 1996;9(1):21–25.

    Google Scholar 

  7. Schmidt C. Venous post-thrombotic disease. Rev Pract 1994; 44(6):745–750.

    Google Scholar 

  8. Callam M. Prevalence of chronic leg ulceration and severe chronic venous disease in western countries. Phlebology 1992;7(Suppl 1):6–12.

    Google Scholar 

  9. Hume M. Presidential address: A venous renaissance? J Vasc Surg 1992;15:947–951.

    Google Scholar 

  10. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of prophylaxis for venous thromboembolism in hospital patients. BMJ 1992;305:567–574.

    Google Scholar 

  11. Nicolaides AN, Arcelus JI, Belcaro G, et al. Prevention of venous thromboembolism. Int Angiol 1992;11:151–159.

    Google Scholar 

  12. Clagett GP, Anderson FA, Heit J, Levine MN, Wheeler HB. Prevention of venous thromboembolism. Chest 1995;108: 312S–334S.

    Google Scholar 

  13. Nicolaides AN, Bergqvist D, Hull RD, et al. Prevention of venous thromboembolism: International consensus statement. Int Angiol 1997;16:3–38.

    Google Scholar 

  14. Caprini Survey unpublished data.

  15. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. Physician practices of venous thromboembolism. Ann Intern Med 1991;115:591–595.

    Google Scholar 

  16. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. Changing clinical practice. Arch Intern Med 1994;154:669–677.

    Google Scholar 

  17. Clagett GP, Anderson FA Jr, Geerts W, et al. Prevention of venous thromboembolism. Chest 1998;114:531S–565S.

    Google Scholar 

  18. Salzman EW, Hirsch J. The epidemiology, pathogenesis, and natural history of venous thrombosis. In: Colman RW, Hirsch J, Marder VJ, Salzman EW (Eds). Haemostasis and Thrombosis: Basic Principles and Clinical Practice, 3rd ed. Philadelphia: Lippincott, 1994:1275–1296.

    Google Scholar 

  19. Caprini JA, et al. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost 1991; 17(3):304–312.

    Google Scholar 

  20. Trousseau A. Lectures on clinical medicine delivered at the Hotel-Dieu Paris. London: New Sydenham Society, 1865: 282–332.

    Google Scholar 

  21. Bergqvist D. Trauma and thrombosis. High risk of embolism in patients with spinal cord injuries, hip fractures, and leg fractures. Lakartidningen 1996;93(30/31):2653–2654.

    Google Scholar 

  22. Engel S, Evans SP, Mikk M, Rozenberg MC, Jones RF. D-Dimer in early diagnosis of thromboembolic disease in acute spinal injuries. Med J Aust 1993;158:705–706.

    Google Scholar 

  23. Gensini GF, Prisco D, Falciani M, et al. Identification of candidates for prevention of venous thromboembolism. Semin Thromb Hemost 1997;23(1):55–67.

    Google Scholar 

  24. Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost 1991;17(3):304–312.

    Google Scholar 

  25. Nicolaides AN, Irving D. Clinical factors and the risk of deep vein thrombosis. In: Nicolaides AN (Ed). Thromboembolism: Aetiology, Advances in Prevention and Treatment. Lancaster: MTP, 1975:194–204.

    Google Scholar 

  26. Hirsch J, Genton E, Hull R. Venous Thromboembolism. New York: Grune & Stratton, 1981.

    Google Scholar 

  27. Nurmohamed MT, Buller HR, ten Cate JW. Physiological changes due to age: Implications for the prevention and treatment of thrombosis in older patients. Drugs Aging 1994;5(1):20–33.

    Google Scholar 

  28. Morrell MT, Dunnill MS. The post-mortem incidence of pulmonary embolism in a hospital population. Br J Surg 1968;55:347–352.

    Google Scholar 

  29. Brenner DW, Fogle MA, Schellhammer PF. Venous thromboembolism. J Urol 1989;142:1403–1411.

    Google Scholar 

  30. Goldhaber SZ, Hirsh DR. Medical risk factors. In: Goldhaber SZ (Ed). Prevention of Venous Thromboembolism. New York: Marcel Dekker, Inc., 1993:51–69.

    Google Scholar 

  31. Smith, JP. Thrombotic complications in intravenous access. J Intraven Nurs 1998;21(2):96–100.

    Google Scholar 

  32. Raad II, Luna M, Sayed-Ahmed MK, et al. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994;271(13):1014–1016.

    Google Scholar 

  33. Kierkegaard A, Norgren L, Olsson C. Incidence of deep vein thrombosis in bedridden non-surgical patients. Acta Med Scand 1987;222:409–411.

    Google Scholar 

  34. Heller KD, Prescher A, Zilkins KW. Anatomic study of femoral vein occlusion during simulated hip arthroplasty. Surg Radiol Anat 1997;19(3):133–137.

    Google Scholar 

  35. White RH, Romano PS, Zhou H, Rodrigo J. Incidence and time course of thromboembolic outcomes following total hip and knee arthroplasty. Arch Intern Med 1998;158(14):1525–1531.

    Google Scholar 

  36. Leclerc JR, Gent M, Hirsch J, et al. The incidence of symptomatic venous thromboembolism during and after hip and knee arthroplasty. Arch Intern Med 1998;158(8):873–878.

    Google Scholar 

  37. Planes A, Vochelle N, Fagola M. Total hip replacement and deep vein thrombosis. JBJS 1990;72(B):9–13.

    Google Scholar 

  38. Visentin GP, Astor RH. Heparin-induced thrombocytopenia and thrombosis. Curr Opin Hematol 1995;2(5):351–357.

    Google Scholar 

  39. Alving BM, Krishnamurti C. Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosis. Semin Thromb Hemost 1997;23(6):569–574.

    Google Scholar 

  40. Montgomery KD, Geerts WH, Potter HG, Helfet DL. Thromboembolic complications in patients with pelvic trauma. Clin Orthop 1996;2(329):68–87.

    Google Scholar 

  41. Montgomery KD, Geerts WH, Potter HG, Helfet DL. Practical management of venous thromboembolism following pelvic fractures. Orthop Clin North Am 1997;28(3):397–404.

    Google Scholar 

  42. Vajanto I, Kuokkanen H, Niskanen R. Complications after treatment of proximal femoral fractures. Ann Surg Gynecol 1998;87(1):49–52.

    Google Scholar 

  43. Feide CF. Deep vein thrombosis: The risks of sclerotherapy in hypercoagulable states. Semin Dermatol 1993;12(2):135–149.

    Google Scholar 

  44. Sagar S, Stamatakis JD, Thomas DP, Kakkar VV. Oral contraceptives, antithrombin III activity and postoperative deep vein thrombosis. Lancet 1976;1:509–511.

    Google Scholar 

  45. Astedt B, Bernstein K, Casslen B, Ulmstein U. Estrogens and postoperative thrombosis evaluated by the radioactive iodine method. Surg Gynecol Obstet 1980;151:372–374.

    Google Scholar 

  46. Bottigeer LE, Boman G, Eklund G, Westerholm B. Oral contraceptives and thromboembolic disease: Effect of lowering estrogen content. Lancet 1980;1:1097–1101.

    Google Scholar 

  47. Eby CS. A review of the hypercoagulable state. Hematol Oncol Clin North Am 1993;7(6):1121–1142.

    Google Scholar 

  48. James KB, Lohr JM, Cranley JJ. Venous thrombotic complications of pregnancy. Cardiovasc Surg 1996;4(6):777–782.

    Google Scholar 

  49. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: Results of International Multi-center Case-Control Study. Lancet 1995;346:1575–1582.

    Google Scholar 

  50. Refsum H, Ueland PM, Nygard O, Vollset, SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49: 31–62.

    Google Scholar 

  51. Stein JH, McBride PE. Hyperhomocysteinemia and atherosclerotic vascular disease: Pathophysiology, screening, and treatment. Arch Intern Med 1998;158:1301–1306.

    Google Scholar 

  52. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood 1997;90(1):1–11.

    Google Scholar 

  53. Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996;27(3): 517–527.

    Google Scholar 

  54. Rees MM, Rodgers GM. Homocysteinemia: Association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 1993;71:337–359.

    Google Scholar 

  55. Gallagher PM, Meleady R, Shields DC. Homocysteine and risk of premature coronary heart disease: Evidence for a common gene mutation. Circulation 1996;94:2154–2158.

    Google Scholar 

  56. Kang SS, Wong PWK, Susmano A. Thermobile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am J Hum Genet 1991;48:546–551.

    Google Scholar 

  57. Selhub J, D'Angelo D. Hyperhomocysteinemia and thrombosis: Acquired conditions. Thromb Haemost 1997;78(1): 527–531.

    Google Scholar 

  58. Boers GH. Hyperhomocysteinemia as a risk factor for arteriole and venous disease. Thromb Haemost 1997;78(1): 520–522.

    Google Scholar 

  59. Kock HJ, Schmit-Neuerberg KP, Hanke J, et al. Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilization of the leg. Lancet 1995;346:459–461.

    Google Scholar 

  60. Bauer G. Thrombosis following leg injuries. Acta Chir Scand 1944;90:229–249.

    Google Scholar 

  61. Spannagel U, Kujath P. Low molecular weight heparin for the prevention of thromboembolism in outpatients immobilized by plaster cast. Semin Thromb Hemost 1993;19(Suppl 1):131–141.

    Google Scholar 

  62. Kujath P, Spannagel U, Habscheid W, et al. Thrombosis prevention in outpatients with lower limb injuries. Dtsch Med Wschr 1992;117:6–10.

    Google Scholar 

  63. Thomas DP. Pathogenesis of venous thrombosis. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (Eds). Haemostasis and Thrombosis, 3rd ed. Edinburgh: Churchill Livingstone, 1994:1335–1347.

    Google Scholar 

  64. Wyshock E, Caldwell M, Crowley JP. Deep vein thrombosis, in_ammatory bowel disease and protein C deficiency. Am J Clin Path 1988;90:633–635.

    Google Scholar 

  65. Caprini JA, Arcelus JI, Laubach M, et al. Postoperative hypercoagulability and deep-vein thrombosis after laparoscopic cholecystectomy. Surg Endosc 1995;9(3):304–309.

    Google Scholar 

  66. Healey MG, Maher PJ, Hill DJ. The risk of venous thrombosis following gynecological laparoscopic surgery. Med J Aust 1998;168(10):524.

    Google Scholar 

  67. Sobolewski AP, Deshmukh RM, Brunson BL. Venous hemodynamic changes during laparoscopic cholecystectomy. J Laparoendosc Surg 1995;5(6):363–569.

    Google Scholar 

  68. Hirsh J, Hull RD. Pathogenesis of venous thromboembolism and clinical risk factors. In: Hirsh J, Hull RD (Eds): Venous Thromboembolism: Natural History, Diagnosis, and Management. Boca Raton: CRC Press, 1987:5–16.

    Google Scholar 

  69. Riber C, Alstrup N, Nymann T, et al. Postoperative thromboembolism after day-case herniorrhaphy. Br J Surg 1996; 83:420–421.

    Google Scholar 

  70. Rodzynek JJ, Damien J, Huberty M. Incidence of preoperative deep venous thrombosis in abdominal surgery. Br J Surg 1984;71:731–732.

    Google Scholar 

  71. Kuby J. Immunology (W.H. Freeman and Company, New York), Third Ed. Life, Death and the Immune System. Scientific American (W.H. Freeman and Company, New York), 1997.

    Google Scholar 

  72. Roberts VC, Cotton LT. Prevention of postoperative deep venous thrombosis in patients with malignant disease. Br Med J 1974;1(904):358–360.

    Google Scholar 

  73. Piccioli A, Prandoni P, Ewenstien BM, Goldhaber SZ. Cancer and venous thromboembolism. Am Hrt J 1996;132(4): 850–855.

    Google Scholar 

  74. Levine MN. Prevention of thrombotic disorders in cancer patients undergoing chemotherapy. Thromb Haemost 1997; 78(1):133–136.

    Google Scholar 

  75. Agnelli G. Venous thromboembolism and cancer: A two-way clinical association. Thromb Haemost 1997;78(1):117–120.

    Google Scholar 

  76. Shackford SR, Davis JW, Hollingsworth-Fridlund P, et al. Venous thromboembolism in patients with major trauma. Am J Surg 1990;159:365–369.

    Google Scholar 

  77. Geerts WH, Code KI, Jay RM, et al. A prospective study of venous thromboembolism after major trauma. N Eng JMed 1994;331:1601–1606.

    Google Scholar 

  78. Nicolaides AN, Kakkar VV, Renney JTG, et al. Myocardial infarction and deep vein thrombosis. Br Med J 1971;1:432–434.

    Google Scholar 

  79. Carter CJ. The natural history and epidemiology of venous thrombosis. Prog Cardiovasc Dis 1994;36(6):423–438.

    Google Scholar 

  80. Andreoli TE, Bennett JC, Carpenter CJ, Plum F, Smith LH. Essentials of Medicine. Philadelphia: W.B. Saunders Company, 1993.

    Google Scholar 

  81. Coon WW. Epidemiology of venous thromboembolism in patients with major trauma. Ann Surg 1977;186:149–164.

    Google Scholar 

  82. Goldhaber SZ, Savage DD, Garrison RJ, et al. Risk factors for pulmonary embolism. Am J Med 1983;74:1023–1028.

    Google Scholar 

  83. Almer LO, Janzon L. Low vascular fibrinolytic activity in obesity. Thromb Res 1976;6:171–176.

    Google Scholar 

  84. Bonnar J. Thromboembolism in obstetric and gynecological patients. In: Nicolaides AN (Ed). Thromboembolism, Aetiology, Advances in Prevention, and Management. Lancaster: MTP, 1975:311–340.

    Google Scholar 

  85. Comp PC. Overview of the hypercoagulable states. Semin Thromb Hemost 1990;16(2):158–161.

    Google Scholar 

  86. Warlow C, Ogston D, Douglas AS. Deep vein thrombosis of the legs after stroke: Incidence and predisposing factors. BMJ 1976;1:1178–1181.

    Google Scholar 

  87. Sevitt S, Gallagher NG. Prevention of venous thrombosis in injured patients. Lancet 1959;2:981–989.

    Google Scholar 

  88. Bergmann JF, Elkharrat D. Prevention of venous thromboembolic risk in non-surgical patients. Haemostasis 1996; 26(Suppl 2):16–23.

    Google Scholar 

  89. Heatley RU, Hughes LE, Morgan A. Pre-operative or postoperative deep vein thrombosis? Lancet 1976;1:437–439.

    Google Scholar 

  90. Gibbs NM. Venous thrombosis of the lower limbs with particular references to bed-rest. Br J Surg 1957;45:209–213.

    Google Scholar 

  91. Coon WW, Clooer FA. Some epidemiological considerations of thromboembolism. Surg Gynecol Obstet 1959;109:487–501.

    Google Scholar 

  92. Jorgensen JO, Hanel KC, Morgan AM, Hunt JM. The incidence of deep venous thrombosis in patients with superficial thrombophlebitis of the lower limbs. J Vasc Surg 1993;18: 70–73.

    Google Scholar 

  93. Shapiro SS. The lupus anticoagulant/antiphospholipid syndrome. Annu Rev Med 1996;47:533–553.

    Google Scholar 

  94. Rand JH. Antiphospholipid antibody syndrome: New insights on thrombogenic mechanisms.Am J Med Sci 1998;316 (2):142–151.

    Google Scholar 

  95. Hughes JR, Davies JA. Anticardiolipin antibodies and clinical conditions associated with a risk of thrombotic events. Thromb Res 1998;89(3):101–106.

    Google Scholar 

  96. Cooper DN, Tuddenham, EGD. Molecular genetics of familial venous thrombosis. BMJ 1994;50(4):833–850.

    Google Scholar 

  97. Castaman G, Ruggeri M, Tosetto M, Rodeghiero F. Low risk of venous thrombosis in two families with combined type I plasminogen deficiency and factor V R506Q mutation. Am J Hematol 1998;57(4):344–347.

    Google Scholar 

  98. Zuger M, Biasiutti FD, Furlam M, Manhalter C, Lammle B. Plasminogen deficiency: Additional risk factor for thrombosis. Thromb Haemost 1996;76(3):475–476.

    Google Scholar 

  99. Paramo JA, Alfaro MJ, Rocha E. Post-operative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor: Relationship to deep vein thrombosis and influence of prophylaxis. Thromb Haemostas 1985;54:713–716.

    Google Scholar 

  100. Clayton JK, Anderson JA, McNicol GP. Pre-operative prediction of post-operative deep vein thrombosis. BMJ 1976;2:910–912.

    Google Scholar 

  101. Bentolila S, Samama SS, Conard J, Horellou MH, French P. Association of dysfibrinogenemia and thrombosis. Ann Med Interne 1995;146(8):575–580.

    Google Scholar 

  102. Dahlback B. Inherited thrombophilia: Resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 1995;85(3):607–614.

    Google Scholar 

  103. Price DT, Ridker PM. Factor V Leiden mutation and the risks for thromboembolic disease: A clinical perspective. Ann Intern Med 1997;127(10):895–903.

    Google Scholar 

  104. Von Tempelhoff GF, Heilmann L, Hommel G, et al. Hyperviscosity syndrome in patients with ovarian carcinoma. Cancer 1998;82(6):1104–1111.

    Google Scholar 

  105. Forester J. Plasma cell dyscrasias: General considerations. In: Lee GR, Forester J, Lukens J, Paraskevas F, Greer JP (Eds) Wintrobe's Clinical Hematology, vol 2. Baltimore: 1998:2612–2630.

  106. Landolfi R, Marchioli R, Petroni C. Mechanisms of bleeding and thrombosis in myeloproliferative disorders. Thromb Haemost 1997;78(1):617–621.

    Google Scholar 

  107. Fiessinger JN. Thrombotic complications of polycythemia. The venous and arterial risk factors. Nouve Rev Fr Hematol 1994;36:179–218.

    Google Scholar 

  108. Margaglione M, Brancaccio V, Giuliani N, et al. Increased risk for venous thrombosis in carriers of the prothrombin G → A20210 gene variant. Ann Intern Med 1998;129(2):89–93.

    Google Scholar 

  109. Reuner KH, Ruf A, Grau A. Prothrombin gene G20210 → A transition is a risk factor for venous thrombosis. Stroke 1998;29(9):1765–1769.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Evanston Northwestern Healthcare, Evanston, IL

    Gary D. Motykie, Lukas P. Zebala, Joseph A. Caprini, Chris E. Lee & Eric B. Cohen

  2. Northwestern University Medical School, Chicago, IL

    Gary D. Motykie, Lukas P. Zebala, Joseph A. Caprini, Chris E. Lee & Eric B. Cohen

  3. Hospital de la Axarquía, Málaga, Spain

    Juan I. Arcelus & J.J. Reyna

Authors
  1. Gary D. Motykie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lukas P. Zebala
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joseph A. Caprini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chris E. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Juan I. Arcelus
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J.J. Reyna
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Eric B. Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph A. Caprini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Motykie, G.D., Zebala, L.P., Caprini, J.A. et al. A Guide to Venous Thromboembolism Risk Factor Assessment. J Thromb Thrombolysis 9, 253–262 (2000). https://doi.org/10.1023/A:1018770712660

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018770712660

Search

Navigation